Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease
Authors:
- 1 September 2017
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 19 (9) , 1096-1112
Abstract
No abstract availableKeywords
Funding Information
- University of California, Los Angeles
- Miltenyi Biotec
This publication has 23 references indexed in Scilit:
- β-globin gene transfer to human bone marrow for sickle cell diseaseJournal of Clinical Investigation, 2013
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtrationJournal of Virological Methods, 2011
- Combinatorial Incorporation of Enhancer-Blocking Components of the Chicken β-Globin 5′HS4 and Human T-Cell Receptor α/δ BEAD-1 Insulators in Self-Inactivating Retroviral Vectors Reduces Their Genotoxic PotentialStem Cells, 2008
- Global epidemiology of haemoglobin disorders and derived service indicatorsBulletin of the World Health Organization, 2008
- Correction of a mouse model of sickle cell disease: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cellsBlood, 2003
- Fatal sickle cell crisis after granulocyte colony-stimulating factor administrationBlood, 2001
- Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantationBone Marrow Transplantation, 2000
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996
- Recombinant human hemoglobins designed for gene therapy of sickle cell disease.Proceedings of the National Academy of Sciences, 1994